Cargando…

Activation of glucagon‐like peptide‐1 receptors and skilled reach foraging

Glucagon‐like peptide‐1 receptor (GLP‐1R) agonists, such as exendin‐4 (Ex4), liraglutide and dulaglutide, regulate glucose homeostasis and are thus used to treat diabetes type II. GLP‐1 also contributes towards a variety of additional physiological functions, including suppression of reward and impr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vestlund, Jesper, Bergquist, Filip, Licheri, Valentina, Adermark, Louise, Jerlhag, Elisabet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Preclinical Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244104/ https://www.ncbi.nlm.nih.gov/pubmed/32770792 http://dx.doi.org/10.1111/adb.12953

Ejemplares similares

Nicotine‐induced neuroplasticity in striatum is subregion‐specific and reversed by motor training on the rotarod
por: Licheri, Valentina, et al.
Publicado: (2019)

The glucagon‐like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents
por: Vallöf, Daniel, et al.
Publicado: (2015)

Activation of glucagon-like peptide-1 receptors reduces the acquisition of aggression-like behaviors in male mice
por: Vestlund, Jesper, et al.
Publicado: (2022)

Central administration of the anorexigenic peptide neuromedin U decreases alcohol intake and attenuates alcohol‐induced reward in rodents
por: Vallöf, Daniel, et al.
Publicado: (2016)

Activation of amylin receptors attenuates alcohol‐mediated behaviours in rodents
por: Kalafateli, Aimilia Lydia, et al.
Publicado: (2018)

Brain region‐specific neuromedin U signalling regulates alcohol‐related behaviours and food intake in rodents
por: Vallöf, Daniel, et al.
Publicado: (2019)

Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system
por: Jerlhag, Elisabet, et al.
Publicado: (2011)

An acetylcholine‐dopamine interaction in the nucleus accumbens and its involvement in ethanol's dopamine‐releasing effect
por: Loftén, Anna, et al.
Publicado: (2020)

Acute and chronic modulation of striatal endocannabinoid‐mediated plasticity by nicotine
por: Adermark, Louise, et al.
Publicado: (2018)

The Anorexigenic Peptide Neuromedin U (NMU) Attenuates Amphetamine-Induced Locomotor Stimulation, Accumbal Dopamine Release and Expression of Conditioned Place Preference in Mice
por: Vallöf, Daniel, et al.
Publicado: (2016)

The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies
por: Jerlhag, Elisabet
Publicado: (2023)

The Glucagon-Like Peptide 1 Analogue, Exendin-4, Attenuates the Rewarding Properties of Psychostimulant Drugs in Mice
por: Egecioglu, Emil, et al.
Publicado: (2013)

Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats
por: Vallöf, Daniel, et al.
Publicado: (2020)

Glucagon-Like Peptide-1–Mediated Cardioprotection Does Not Reduce Right Ventricular Stunning and Cumulative Ischemic Dysfunction After Coronary Balloon Occlusion
por: Giblett, Joel P., et al.
Publicado: (2019)

Glucagon Receptor Antagonism Ameliorates Progression of Heart Failure
por: Gao, Chen, et al.
Publicado: (2019)

Glucagon-Like Peptide-1 Protects Against Atrial Fibrillation and Atrial Remodeling in Type 2 Diabetic Mice
por: Bohne, Loryn J., et al.
Publicado: (2023)

The Glucagon-Like Peptide 1 Analogue Exendin-4 Attenuates the Nicotine-Induced Locomotor Stimulation, Accumbal Dopamine Release, Conditioned Place Preference as well as the Expression of Locomotor Sensitization in Mice
por: Egecioglu, Emil, et al.
Publicado: (2013)

Salmon Calcitonin Attenuates Some Behavioural Responses to Nicotine in Male Mice
por: Aranäs, Cajsa, et al.
Publicado: (2021)

Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties
por: Kundu, Namita, et al.
Publicado: (2013)

Functional inhibition of F11 receptor (F11R/junctional adhesion molecule-A/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment
por: Bednarek, Radoslaw, et al.
Publicado: (2019)

Abstinence-Induced Nicotine Seeking Relays on a Persistent Hypoglutamatergic State within the Amygdalo-Striatal Neurocircuitry
por: Domi, Ana, et al.
Publicado: (2023)

Medial habenula cholinergic signaling regulates cocaine‐associated relapse‐like behavior
por: López, Alberto J., et al.
Publicado: (2018)

Increased gene expression variability in BRCA1-associated and basal-like breast tumours
por: Wiggins, George A. R., et al.
Publicado: (2021)

Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus
por: Patel, Vishal J, et al.
Publicado: (2018)

Sex differences in binge‐like EtOH drinking, corticotropin‐releasing hormone and corticosterone: effects of β‐endorphin
por: Nentwig, Todd B., et al.
Publicado: (2018)

Ghrelin increases intake of rewarding food in rodents
por: Egecioglu, Emil, et al.
Publicado: (2010)

Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival
por: Weigman, Victor J., et al.
Publicado: (2011)

Anhedonic- and anxiogenic-like behaviors and neurochemical alterations are abolished by a single administration of a selenium-containing compound in chronically stressed mice
por: Casaril, Angela Maria, et al.
Publicado: (2021)

Paired-like Homeodomain Transcription factor 2 expression by breast cancer bone marrow disseminated tumor cells is associated with early recurrent disease development
por: Pillai, Sreeraj G., et al.
Publicado: (2015)

Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes
por: Teinturier, Romain, et al.
Publicado: (2021)

A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer
por: Hollern, Daniel P., et al.
Publicado: (2018)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

How glucagon-like peptide 1 receptor agonists work
por: Andreasen, Christine Rode, et al.
Publicado: (2021)

Stability of glucagon-like peptide 1 and glucagon in human plasma
por: Wewer Albrechtsen, Nicolai J, et al.
Publicado: (2015)

SEARCHBreast: a new resource to locate and share surplus archival material from breast cancer animal models to help address the 3Rs
por: Blyth, Karen, et al.
Publicado: (2016)

Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study
por: Jinna, Nikita D., et al.
Publicado: (2023)

Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnostics
por: Groenendijk, Floris H., et al.
Publicado: (2013)

Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach
por: Dekker, T. J. A., et al.
Publicado: (2015)

A prospective cohort study of clinical characteristics and outcomes in Chinese patients with estrogen receptor-negative/progesterone receptor-positive early breast cancer
por: Fan, Yu, et al.
Publicado: (2023)

Inhibition of alpha7 nicotinic receptors in the ventral hippocampus selectively attenuates reinstatement of morphine‐conditioned place preference and associated changes in AMPA receptor binding
por: Wright, Victoria L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jnnftunb6hkbt0ajai1lfgkplk